IRIS

Articolo pubblicato su Rivista: [38605] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 38.605
Titolo Data di pubblicazione Autore(i) File
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer 1-gen-2017 Conteduca, V.; Scarpi, E.; Caroli, P.; Salvi, Simone; Lolli, Claudio; Burgio, Salvatore Luca; DI MENNA, CLOTILDE LETIZIA; Schepisi, G.; Testoni, Sara; Gurioli, G.; Paganelli, Giovanni; Casadio, Vanessa; Matteucci, F.; DE GIORGI, UGO FEDERICO FRANCESCO
Expectations of survivors, caregivers and healthcare providers for testicular cancer survivorship and quality of life 1-gen-2011 De Padova, S; Rosti, G; Scarpi, E; Salvioni, R; Amadori, D; De Giorgi, U
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer 1-gen-2015 Santoni, M; Crabb, Sj; Conti, A; Rossi, L; Burattini, L; Conteduca, V; Chau, C; Burgio, Sl; Muzzonigro, G; Cascinu, S; De Giorgi, U
Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer 1-gen-2007 De Giorgi, U; Rosti, G; Ciucci, G; Kopf, B; Minzi, C; Argnani, M; Marangolo, M.
Brain metastases in patients with germ cell tumors: Prognostic factors and treatment options - An analysis from the Global Germ Cell Cancer Group 1-gen-2016 Feldman, Dr; Lorch, A; Kramar, A; Albany, C; Einhorn, Lh; Giannatempo, P; Necchi, A; Flechon, A; Boyle, H; Chung, P; Huddart, Ra; Bokemeyer, C; Tryakin, A; Sava, T; Winquist, Ew; De Giorgi, U; Aparicio, J; Sweeney, Cj; Cohn Cedermark, G; Beyer, J; Powles, T
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer 1-gen-2015 Rossi, L; Santoni, M; Crabb, Sj; Scarpi, E; Burattini, L; Chau, C; Bianchi, E; Savini, A; Burgio, Sl; Conti, A; Conteduca, V; Cascinu, S; De Giorgi, U
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases 1-gen-2010 De Giorgi, U; Mego, M; Rohren, E; Liu, P; Handy, Bc; Reuben, Jm; Macapinlac, Ha; Hortobagyi, Gn; Cristofanilli, M; Ueno, Nt.
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer 1-gen-2017 Conteduca, V; Scarpi, E; Caroli, P; Salvi, S; Lolli, C; Burgio, Sl; Menna, C; Schepisi, G; Testoni, S; Gurioli, G; Paganelli, G; Casadio, V; Matteucci, F; De Giorgi, U
Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5] 1-gen-2015 DE GIORGI, Ugo; Caroli, Paola; Scarpi, Emanuela; Conteduca, Vincenza; Burgio, Salvatore Luca; Menna, Cecilia; Moretti, Andrea; Galassi, Riccardo; Rossi, Lorena; Amadori, Dino; Paganelli, Giovanni; Matteucci, Federica
Germ-cell tumors 1-gen-2007 De Giorgi, U; Pedrazzoli, P; Rosti, G
[177 Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet? 1-gen-2018 Paganelli, Giovanni; De Giorgi, Ugo
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma 1-gen-2013 Santoni, M; De Giorgi, U; Iacovelli, R; Conti, A; Burattini, L; Rossi, L; Luca Burgio, S; Berardi, R; Muzzonigro, G; Cortesi, E; Amadori, D; Cascinu, S.
Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone 1-gen-2014 Burgio, Sl; Conteduca, V; Menna, C; Carretta, E; Rossi, L; Bianchi, E; Kopf, B; Fabbri, F; Amadori, D; De Giorgi, U
Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome 1-gen-2014 Pignatta, S; Arienti, C; Zoli, W; Di Donato, M; Castoria, G; Gabucci, E; Casadio, V; Falconi, M; De Giorgi, U; Silvestrini, R; Tesei, A
Consider quality of life to improve quality of cancer guidelines 1-gen-2017 Schepisi, G; Banna, Gl; De Giorgi, U
Onycholysis secondary to multiple paclitaxel 1-hour infusions: possible role for its vehicle (Cremophor EL) 1-gen-2003 De Giorgi, U; Rosti, G; Monti, M; Frassineti, Gl; Marangolo, M.
A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients 1-gen-2012 Eechoute, K; Fransson, Mn; Reyners, Ak; de Jong, Fa; Sparreboom, A; van der Graaf, Wt; Friberg, Le; Schiavon, G; Wiemer, Ea; Verweij, J; Loos, Wj; Mathijssen, Rh; De Giorgi, U
CAR-T cell therapy: A potential new strategy against prostate cancer 1-gen-2019 Schepisi, G.; Cursano, M. C.; Casadei, C.; Menna, C.; Altavilla, A.; Lolli, C.; Cerchione, C.; Paganelli, G.; Santini, D.; Tonini, G.; Martinelli, G.; De Giorgi, U.
Follow-up strategy of germ cell tumour patients 1-gen-2006 De Giorgi, U; Tana, S; Rosti, G.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients 1-gen-2015 Conteduca, V; Caffo, O; Fratino, L; Lo Re, G; Basso, U; D'Angelo, A; Donini, M; Verderame, F; Ratta, R; Procopio, G; Campadelli, E; Massari, F; Gasparro, D; Ermacora, P; Messina, C; Giordano, M; Alesini, D; Zagonel, V; Veccia, A; Lolli, C; Maines, F; De Giorgi, U
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 38.605
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 03 Articolo su Rivista38605
Autore
  • SPAGNOLO, Stefania Antonia1590
  • GORINI, Edoardo1578
  • VENTURA, Andrea1508
  • PRIMAVERA, Margherita1313
  • CHIODINI, GABRIELE1056
  • GRAVILI, FRANCESCO GIUSEPPE648
  • GIGLI, Giuseppe468
  • CINGOLANI, Roberto438
  • DE GIORGI, UGO FEDERICO FRANCESCO437
  • LONGO, LUIGI388
Data di pubblicazione
  • In corso di stampa43
  • 2020 - 202710433
  • 2010 - 201913552
  • 2000 - 20098692
  • 1990 - 19993962
  • 1980 - 19891442
  • 1970 - 1979447
  • 1961 - 196934
Editore
  • Elsevier BV:PO Box 211, 1000 AE A...454
  • American Institute of Physics:2 H...272
  • Giuffre Editore Spa:via Busto Ars...128
  • Elsevier Science Limited:Oxford F...99
  • Congedo Editore Luogo pubbl. Gal...72
  • IOP Publishing Limited:Dirac Hous...71
  • Springer Verlag Germany:Tiergarte...71
  • Kluwer Academic Publishers:Journa...54
  • IEEE / Institute of Electrical an...47
  • Societa Editrice il Mulino Spa:St...43
Rivista
  • JOURNAL OF HIGH ENERGY PHYSICS481
  • THE EUROPEAN PHYSICAL JOURNAL. C,...393
  • PHYSICS LETTERS. SECTION B392
  • PHYSICAL REVIEW LETTERS211
  • APPLIED PHYSICS LETTERS186
  • NUCLEAR INSTRUMENTS AND METHODS I...185
  • THE ASTROPHYSICAL JOURNAL180
  • PHYSICAL REVIEW D, PARTICLES, FIE...156
  • PHYSICAL REVIEW D148
  • ITINERARI DI RICERCA STORICA140
Keyword
  • ATLAS1158
  • LHC1151
  • High Energy Physics1130
  • Humans376
  • Mediterranean Sea185
  • Italy177
  • Female144
  • Animals143
  • Male127
  • Hadron-Hadron Scattering122
Lingua
  • eng25985
  • ita9002
  • fre415
  • spa191
  • ger146
  • por94
  • lat51
  • grc47
  • rus43
  • chi13
Accesso al fulltext
  • no fulltext32279
  • open4081
  • restricted1185
  • reserved1012
  • partially open32
  • mixed10
  • embargoed6